IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer. Cui Z, Liang H, Luo R, Huang W, et al. J Cancer Res Clin Oncol 2024;150:363.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cui Z, Liang H, Luo R, Huang W, et al. IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer. J Cancer Res Clin Oncol 2024;150:363.
PMID: 39052108